Detailed price information for Marker Therapeutics Inc (MRKR-Q) from The Globe and Mail including charting and trades.
The Dermatology Division of the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to sonelokimab (SLK) in moderate-to-severe palmoplantar pustulosis (PPP) supported by ...
Plan to resume MAGNITUDE-2 patient enrollment and dosing FDA engagement ongoing regarding clinical hold on MAGNITUDE Phase 3 ...
The Dermatology Division of the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to sonelokimab (SLK) in moderate-to-severe palmoplantar pustulosis (PPP) supported by positiv ...
Discusses Zydus Collaboration, Global Manufacturing Expansion, and Patient Access Initiatives January 28, 2026 4:00 PM ...
Cullough of Wiley Rein LLP discuss the Department of Justice Criminal Division's Fraud Section year in review, including ...
Publication includes a systematic review of 24 studies describing off-label cutaneous application of statins in porokeratosis ...
Are GLP-1 drugs prescribed for weight loss becoming too outsized a line item for continued coverage through the state Medicaid program? That’s what Gov. Dan McKee’s fiscal year 2027 budget suggests.
In 2025, the U.S. Food and Drug Administration (“FDA”) and U.S. Department of Justice (“DOJ”) pursued significant criminal, ...
Kylie Jimenez is a seasoned global HR executive with more than 20 years of experience in shaping and scaling international organizations. She will join BioNTech from the international manufacturing ...
FDA approvals, trial progress and early commercial momentum put several ASX healthcare companies in a strong position heading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results